155 related articles for article (PubMed ID: 21275934)
1. Hepatocellular carcinoma in older adults: clinical features, treatments, and survival.
Lee SH; Choi HC; Jeong SH; Lee KH; Chung JI; Park YS; Hwang JH; Kim JW; Kim N; Lee DH; Choi HC; Yoon CJ; Kang SG
J Am Geriatr Soc; 2011 Feb; 59(2):241-50. PubMed ID: 21275934
[TBL] [Abstract][Full Text] [Related]
2. Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):1872-7. PubMed ID: 14696422
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients?
Yoo DJ; Kim KM; Jin YJ; Shim JH; Ko GY; Yoon HK; Sung KB; Lee JL; Kang YK; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2011 Jan; 26(1):145-54. PubMed ID: 21175808
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous rupture of hepatocellular carcinoma: a review of 172 Japanese cases.
Miyamoto M; Sudo T; Kuyama T
Am J Gastroenterol; 1991 Jan; 86(1):67-71. PubMed ID: 1846058
[TBL] [Abstract][Full Text] [Related]
5. A new prognostic system for hepatocellular carcinoma including recurrent cases: a study of 861 patients in a single institution.
Toyama T; Hiramatsu N; Yakushijin T; Oze T; Nakanishi F; Yasumaru M; Mochizuki K; Kanto T; Takehara T; Kasahara A; Hayashi N
J Clin Gastroenterol; 2008 Mar; 42(3):317-22. PubMed ID: 18223490
[TBL] [Abstract][Full Text] [Related]
6. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
Cucchetti A; Piscaglia F; Caturelli E; Benvegnù L; Vivarelli M; Ercolani G; Cescon M; Ravaioli M; Grazi GL; Bolondi L; Pinna AD
Ann Surg Oncol; 2009 Feb; 16(2):413-22. PubMed ID: 19034578
[TBL] [Abstract][Full Text] [Related]
7. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
[TBL] [Abstract][Full Text] [Related]
8. Optimal treatment strategy for elderly patients with hepatocellular carcinoma.
Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H
J Gastroenterol Hepatol; 2004 Aug; 19(8):859-65. PubMed ID: 15242487
[TBL] [Abstract][Full Text] [Related]
9. Pain at presentation and survival in hepatocellular carcinoma.
Carr BI; Pujol L
J Pain; 2010 Oct; 11(10):988-93. PubMed ID: 20418170
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the clinical characteristics and prognostic factors of ruptured hepatocellular carcinoma].
Kim YI; Ki HS; Kim MH; Cho DK; Cho SB; Joo YE; Kim HS; Choi SK; Rew JS
Korean J Hepatol; 2009 Jun; 15(2):148-58. PubMed ID: 19581767
[TBL] [Abstract][Full Text] [Related]
11. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.
Stuart KE; Anand AJ; Jenkins RL
Cancer; 1996 Jun; 77(11):2217-22. PubMed ID: 8635087
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age.
Hazama H; Omagari K; Matsuo I; Masuda J; Ohba K; Sakimura K; Kinoshita H; Isomoto H; Murase K; Kohno S
Hepatogastroenterology; 2001; 48(42):1692-6. PubMed ID: 11813602
[TBL] [Abstract][Full Text] [Related]
14. Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease.
Kemp W; Pianko S; Nguyen S; Bailey MJ; Roberts SK
J Gastroenterol Hepatol; 2005 Jun; 20(6):873-81. PubMed ID: 15946134
[TBL] [Abstract][Full Text] [Related]
15. Optimal management of hepatocellular carcinoma: challenges and opportunities.
Lin CL; Kao JH
J Gastroenterol Hepatol; 2010 Aug; 25(8):1336-8. PubMed ID: 20659219
[No Abstract] [Full Text] [Related]
16. Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma.
Jaeck D; Bronowicki JP; Boudejma K; Bachellier P; Chone L; Nisand G; Bazin C; Pflumio F; Uhl G; Wenger JJ; Boissel P; Bigard MA; Gaucher P; Vetter D; Wolf P; Doffoel M
Wiad Lek; 1997; 50 Suppl 1 Pt 1():413-5. PubMed ID: 9383352
[No Abstract] [Full Text] [Related]
17. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
[TBL] [Abstract][Full Text] [Related]
18. Screening for hepatocellular carcinoma.
Haydon GH; Hayes PC
Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):856-60. PubMed ID: 8889450
[TBL] [Abstract][Full Text] [Related]
19. The use of percutaneous ethanol injection therapy for recurrence of hepatocellular carcinoma.
Kotoh K; Sakai H; Morotomi I; Nawata H
Hepatogastroenterology; 1995 Jul; 42(3):197-200. PubMed ID: 7590564
[TBL] [Abstract][Full Text] [Related]
20. Does postembolization fever after chemoembolization have prognostic significance for survival in patients with unresectable hepatocellular carcinoma?
Shim JH; Park JW; Choi JI; Kim HB; Lee WJ; Kim CM
J Vasc Interv Radiol; 2009 Feb; 20(2):209-16. PubMed ID: 19084432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
